ADC Therapeutics
ADCT
$4.34
Share price
-2.25%
Change (1 day)
123.71%
Change (1 year)
Categories
ADC Therapeutics (ADCT) - P/B ratio
P/B ratio as of April 2024 : -2.41
According to ADC Therapeutics's latest financial reports the company has a price-to-book ratio of -2.41.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
ADC Therapeutics - P/B ratio (from 2020 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | -0.9030 | -124.06% |
| 2022-12-31 | 3.75 | -59.78% |
| 2021-12-31 | 9.33 | 27.48% |
| 2020-12-31 | 7.32 | |
| 2019-12-31 | N/A | |
| 2018-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.43 | -200.72% | 🇺🇸 USA |